Cases
Vascular Solutions, Inc. (NASDAQ: VASC)
Merger
Overview
Overview
- Date:
- 2/2/2017
- Company Name:
- Vascular Solutions, Inc.
- Stock Symbol:
- VASC
- Company Name - Buyer:
- Teleflex Incorporated
- Class Period:
- FROM 1/27/2017
- Status:
- Closed/Complete
- Merger Announcement Date:
- 12/2/2016
- Court:
- U.S. District Court: District of Delaware
NEW YORK, February 2, 2017 – Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the District of Minnesota on behalf of all persons or entities who held Vascular Solutions, Inc. (NASDAQ: VASC) securities on January 27, 2017 (the “Class Period”).
On December 2, 2016, the two parties announced the signing of a definitive merger agreement pursuant to which Teleflex Incorporated will acquire Vascular Solutions, Inc. in a deal worth $1 billion. As a result of the merger, Vascular Solutions shareholders are only anticipated to receive $56.00 in cash for each share of Vascular common stock.
The complaint alleges that the company failed to conduct a fair sales process and failed to disclose all material information regarding the sale of the company.
If you held Vascular securities during the Class Period, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa A. Fortunato, Esq. by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.
On December 2, 2016, the two parties announced the signing of a definitive merger agreement pursuant to which Teleflex Incorporated will acquire Vascular Solutions, Inc. in a deal worth $1 billion. As a result of the merger, Vascular Solutions shareholders are only anticipated to receive $56.00 in cash for each share of Vascular common stock.
The complaint alleges that the company failed to conduct a fair sales process and failed to disclose all material information regarding the sale of the company.
If you held Vascular securities during the Class Period, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa A. Fortunato, Esq. by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.